These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12075218)

  • 1. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines.
    Ramirez AL; Reeck J; Maas CS
    Otolaryngol Head Neck Surg; 2002 May; 126(5):459-67. PubMed ID: 12075218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study.
    Lee DH; Kang SM; Feneran A; Youn CS; Kim JK; Cho S; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e1-7. PubMed ID: 23030660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
    Flynn TC; Clark RE
    Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
    Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R
    Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC; Carruthers JA; Carruthers JA; Clark RE
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines.
    Kim EJ; Ramirez AL; Reeck JB; Maas CS
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):88S-93S; discussion 94S-97S. PubMed ID: 14504489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Botulinum toxin-a injection for facial wrinkles: a histological and immunohistochemical evaluation.
    El-Domyati M; Attia SK; El-Sawy AE; Moftah NH; Nasif GA; Medhat W; Marwan B
    J Cosmet Dermatol; 2015 Jun; 14(2):140-4. PubMed ID: 25916463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
    Brashear A
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of overactive bladder with botulinum toxin type B: a pilot study.
    Dykstra D; Enriquez A; Valley M
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):424-6. PubMed ID: 14677005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis.
    Spencer JM; Gordon M; Goldberg DJ
    J Cosmet Laser Ther; 2002 Mar; 4(1):19-23. PubMed ID: 12079633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.